Junel

Pregnancy Prevention

Junel is indicated for the prevention of pregnancy in women who choose to use oral contraceptives. It is a combination pill that contains two types of female hormones: an estrogen and a progestin.

How It Works

This medication prevents pregnancy by interfering with the normal reproductive cycle. It primarily works by:

• Stopping the release of an egg from the ovaries (ovulation).
• Thickening the cervical mucus, which makes it harder for sperm to reach an egg.
• Changing the lining of the uterus to make it less likely for a fertilized egg to attach.

Other Potential Benefits

Beyond preventing pregnancy, combination birth control pills like Junel are sometimes used to help manage menstrual-related concerns. These may include:

• Making menstrual periods more regular and predictable.
• Reducing the amount of blood loss during menstruation.
• Decreasing the severity of painful menstrual cramps.

Junel does not provide protection against HIV infection (AIDS) or other sexually transmitted diseases.

Mechanism of Action

Junel contains two types of hormones: a progestin (norethindrone acetate) and an estrogen (ethinyl estradiol). These hormones work together to prevent pregnancy in three main ways:

• Inhibiting Ovulation: The primary function of Junel is to suppress the release of gonadotropins, which are hormones that trigger the ovaries to release an egg. By keeping hormone levels steady, the medication prevents the monthly release of an egg.
• Thickening Cervical Mucus: The medication increases the thickness of the mucus at the opening of the uterus (the cervix). This creates a barrier that makes it much harder for sperm to swim through the cervix and reach the upper reproductive tract.
• Altering the Uterine Lining: Junel changes the characteristics of the endometrium, which is the lining of the uterus. This change makes the environment less receptive for a fertilized egg to attach to the uterine wall and develop.

While these actions are highly effective at preventing pregnancy when the medication is taken correctly, they do not protect against HIV infection or other sexually transmitted diseases.

Common Side Effects

Common side effects of Junel may include:

• Nausea, vomiting, or stomach cramps
• Bloating
• Headache or migraine
• Breast tenderness, swelling, or discharge
• Changes in weight or appetite
• Vaginal itching or discharge
• Changes in menstrual periods or spotting
• Darkening of facial skin
• Decreased sex drive

Serious Side Effects

Seek emergency medical help if you have signs of an allergic reaction, such as hives, difficulty breathing, or swelling of your face, lips, tongue, or throat. Contact your doctor immediately if you experience:

• Signs of a blood clot: Sudden numbness or weakness, severe headache, vision or speech problems, chest pain, shortness of breath, or swelling and warmth in one or both legs.
• Liver problems: Upper stomach pain, loss of appetite, dark urine, or yellowing of the skin or eyes.
• Cardiovascular issues: Symptoms of high blood pressure, such as blurred vision or pounding in the ears.
• Mood changes: New or worsening depression, sleep problems, or sudden mood shifts.
• Gallbladder disease: Severe pain in the upper abdomen.

Cardiovascular Risks and Smoking

Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptives. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives are strongly advised not to smoke.

Thromboembolic Disorders

The use of Junel is associated with an increased risk of several serious conditions, including:

• Blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism)
• Stroke
• Heart attack

The risk of these events is highest during the first year of use or when restarting hormonal contraception after a break of four weeks or longer.

Contraindications

Junel should not be used by individuals with certain medical conditions, including:

• A history of blood clots, heart attack, or stroke
• Known or suspected breast cancer or other estrogen-dependent cancers
• Uncontrolled high blood pressure
• Liver tumors or active liver disease
• Undiagnosed abnormal uterine bleeding
• Pregnancy

Other Precautions

Liver Function: Discontinue use if jaundice (yellowing of the skin or eyes) develops. Steroid hormones may be poorly metabolized in patients with impaired liver function.

Blood Pressure: Regular blood pressure monitoring is recommended, as some users may experience significant increases.

Glucose and Lipid Metabolism: Users with prediabetes or diabetes should be closely monitored, as oral contraceptives can decrease glucose tolerance and affect lipid levels.

Headache: The onset or worsening of migraines or the development of a new pattern of severe headache requires evaluation and may necessitate stopping the medication.

Bleeding Irregularities: Breakthrough bleeding and spotting may occur, especially during the first three months of use. If bleeding is persistent or severe, healthcare providers should investigate other causes.

Pregnancy

Junel is used to prevent pregnancy and should not be taken by individuals who are already pregnant. If you suspect you are pregnant or have a confirmed pregnancy while taking this medication, you should stop use immediately and consult a healthcare professional.

Studies have generally shown that the accidental use of oral contraceptives during early pregnancy does not appear to increase the risk of birth defects or cause harm to the developing fetus. However, there is no medical reason to continue taking birth control once pregnancy has occurred.

Breastfeeding

The hormones in Junel can pass into breast milk in small amounts. While the specific effects on a nursing infant are not fully established, the use of combined oral contraceptives like Junel may lead to a decrease in the amount of breast milk produced.

Healthcare providers typically recommend using other forms of contraception until a nursing infant is completely weaned. It is important to discuss the timing and choice of birth control with a clinician to determine the most appropriate option while breastfeeding.

Available Forms

Junel is supplied as oral tablets. The medication is packaged in blister cards to facilitate a daily dosing schedule.

Tablet Types

Depending on the specific product, the blister pack may contain different types of tablets:

• Hormonal Tablets: These are the active tablets used for pregnancy prevention.
• Reminder Tablets: Some versions include inert tablets that do not contain hormones. These are intended to be taken daily to maintain the habit of taking the pill.
• Iron-Containing Tablets: In certain formulations, the reminder tablets include iron.

The tablets are typically different colors to help the user distinguish between the active and inactive portions of the regimen.

FDA Approval and Indications

Junel (norethindrone acetate and ethinyl estradiol tablets) is approved by the U.S. Food and Drug Administration (FDA) for the prevention of pregnancy in women who choose to use oral contraceptives as a method of birth control. It is classified as a combination hormonal contraceptive because it contains both an estrogen and a progestin.

Boxed Warning

The FDA-approved labeling for Junel includes a boxed warning concerning the risks associated with cigarette smoking. Clinical data indicates that smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk is particularly high in:

• Women over 35 years of age.
• Women who smoke heavily (15 or more cigarettes per day).

Due to these risks, combination oral contraceptives like Junel are contraindicated in women who are older than 35 and smoke.

Regulatory Requirements

There is currently no Risk Evaluation and Mitigation Strategy (REMS) required for Junel. However, the FDA requires that a Patient Package Insert be provided to every patient with each prescription. This document outlines the effectiveness of the medication, its side effects, and the risks associated with hormonal birth control to ensure informed use.

Withdrawal Bleeding

The bleeding that occurs during the seven days you are not taking active Junel pills (or while taking the inactive placebo pills) is called withdrawal bleeding. This is caused by the drop in hormone levels in your system and is not the same as a natural menstrual period.

Discontinuing Junel

You can stop taking Junel at any time. Because the hormones do not stay in your system for long, the contraceptive effect ends quickly after your last dose. If you do not wish to become pregnant, you should begin an alternative method of birth control immediately after stopping Junel.

What to Expect After Stopping

After you stop taking this medication, your body will begin to resume its natural hormonal cycle. You may notice the following:

• Return of fertility: Ovulation usually resumes within a short time, and pregnancy is possible during your first cycle off the pill.
• Menstrual cycle changes: It may take a few months for your natural period to become regular again. Some people experience irregular cycles or a temporary absence of menstruation, especially if they had irregular periods before starting birth control.
• Return of previous symptoms: If you were using Junel to treat conditions like acne or heavy, painful periods, those symptoms may return once the medication is stopped.

If your period does not return within two to three months after stopping Junel, it is advisable to consult a healthcare provider to ensure there are no underlying issues.